Kristian Stengaard-Pedersen

Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

To investigate the expression of the soluble form of the resident macrophage marker CD163 (sCD163) and its association with core parameters for disease activity, including radiographic progression in early rheumatoid arthritis (RA).
Original languageEnglish
JournalClinical and Experimental Rheumatology
Volume29
Issue4
Pages (from-to)689-92
Number of pages4
ISSN0392-856X
Publication statusPublished - Jul 2011

    Research areas

  • Aged, Aged, 80 and over, Antigens, CD, Antigens, Differentiation, Myelomonocytic, Antirheumatic Agents, Arthritis, Rheumatoid, Biological Markers, Blood Sedimentation, C-Reactive Protein, Denmark, Disease Progression, Double-Blind Method, Drug Therapy, Combination, Early Diagnosis, Female, Humans, Longitudinal Studies, Macrophages, Male, Middle Aged, Osteoarthritis, Predictive Value of Tests, Receptors, Cell Surface, Synovial Fluid, Time Factors, Treatment Outcome

See relations at Aarhus University Citationformats

ID: 44429736